Harvard Bioscience (HBIO) EBIT Growth (3y) (2013 - 2026)
Harvard Bioscience (HBIO) EBIT Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 65.98% |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 28.02% |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | -47.09% |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | - |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 18.46% |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | -0.62% |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | -32.42% |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | -39.46% |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 2.06% |
| 10 | Harvard Bioscience | 28.05 Mn | 20.96 Mn | 12.24 Mn | -38.75% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -38.75% |
| Dec 31, 2025 | 79.07% |
| Sep 30, 2025 | 27.08% |
| Jun 30, 2025 | -30.15% |
| Mar 31, 2025 | -94.87% |
| Dec 31, 2024 | -81.36% |
| Sep 30, 2024 | -75.65% |
| Jun 30, 2024 | -235.23% |
| Mar 31, 2024 | -112.06% |
| Dec 31, 2023 | -53.23% |
| Sep 30, 2023 | -92.44% |
| Jun 30, 2023 | 12.71% |
| Mar 31, 2023 | 36.34% |
| Dec 31, 2022 | -31.61% |
| Sep 30, 2022 | -40.20% |
| Jun 30, 2022 | 159.80% |
| Mar 31, 2022 | -282.43% |
| Dec 31, 2021 | -0.83% |
| Sep 30, 2021 | -14.93% |
| Jun 30, 2021 | 29.10% |